Kazia Therapeutics (KZIA) EPS (Basic) (2011 - 2017)
Kazia Therapeutics (KZIA) posted EPS (Basic) of -$0.87 for Q2 2017, up 93.71% on a QoQ basis from -$13.86 in Q4 2016, and up 17.81% year-over-year from -$0.74 in Q2 2016.
Kazia Therapeutics (KZIA) EPS (Basic) (2011 - 2017) Analysis & Trends
Kazia Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.87 for Q2 2017.
- Quarterly EPS (Basic) rose 17.81% year-over-year to -$0.87 in Q2 2017, while the trailing twelve-month figure through Dec 2018 was -$8.44 (up 59.96% YoY) and the FY2025 annual result came in at -$0.03, up 57.21% from the prior year.
- EPS (Basic) was -$0.87 for Q2 2017 at Kazia Therapeutics, up from -$13.86 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.87 in Q2 2017 and bottomed at -$53.3 million in Q4 2013.
- A 5-year average of -$8.9 million and a median of -$19.3 in 2016 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2013 — EPS (Basic) sank 178664523.99% — and 2014, when it jumped 100.0%.
- Kazia Therapeutics' EPS (Basic) stood at -$53.3 million in 2013, then jumped by 100.0% to -$73.43 in 2014, then jumped by 66.31% to -$24.73 in 2015, then surged by 43.95% to -$13.86 in 2016, then jumped by 93.71% to -$0.87 in 2017.
- Business Quant data shows KZIA's EPS (Basic) at -$0.87 in Q2 2017, -$13.86 in Q4 2016, and -$1.06 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Kazia Therapeutics | 19.25 Bn | 19.25 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -0.87 |
| Dec 31, 2016 | -13.86 |
| Jun 30, 2016 | -1.06 |
| Dec 31, 2015 | -24.73 |
| Dec 31, 2014 | -73.43 |
| Dec 31, 2013 | -53.28 Mn |
| Dec 31, 2012 | -29.82 |
| Oct 8, 2012 | -222.85 |
| Dec 31, 2011 | 295.99 |